Specifically, we investigated the ability of dementia-modulated OMdP in bEVs to interact with proteins that are traditionally linked to AD neuropathology, such as amyloid precursor protein (APP), prion protein (PrP), tau protein (TAU), and PSEN1, as depicted in Figure 6A. This evidence concerns the gene APP and Alzheimer disease.